Washington Trust’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-399
| Closed | -$13.6K | – | 351 |
|
|
2025
Q1 | $13.6K | Sell |
399
-376
| -49% | -$12.8K | ﹤0.01% | 567 |
|
|
2024
Q4 | $30.5K | Hold |
775
| – | – | ﹤0.01% | 513 |
|
|
2024
Q3 | $36.4K | Hold |
775
| – | – | ﹤0.01% | 501 |
|
|
2024
Q2 | $41.9K | Hold |
775
| – | – | ﹤0.01% | 468 |
|
|
2024
Q1 | $52.8K | Hold |
775
| – | – | ﹤0.01% | 447 |
|
|
2023
Q4 | $48.5K | Hold |
775
| – | – | ﹤0.01% | 432 |
|
|
2023
Q3 | $35.2K | Hold |
775
| – | – | ﹤0.01% | 446 |
|
|
2023
Q2 | $43.5K | Hold |
775
| – | – | ﹤0.01% | 439 |
|
|
2023
Q1 | $35.1K | Hold |
775
| – | – | ﹤0.01% | 469 |
|
|
2022
Q4 | $31.5K | Buy |
775
+184
| +31% | +$7.48K | ﹤0.01% | 477 |
|
|
2022
Q3 | $39K | Hold |
591
| – | – | ﹤0.01% | 432 |
|
|
2022
Q2 | $36K | Hold |
591
| – | – | ﹤0.01% | 456 |
|
|
2022
Q1 | $37K | Buy |
591
+9
| +2% | +$563 | ﹤0.01% | 477 |
|
|
2021
Q4 | $44K | Sell |
582
-399
| -41% | -$30.2K | ﹤0.01% | 459 |
|
|
2021
Q3 | $109K | Hold |
981
| – | – | ﹤0.01% | 389 |
|
|
2021
Q2 | $158K | Hold |
981
| – | – | ﹤0.01% | 343 |
|
|
2021
Q1 | $119K | Buy |
981
+310
| +46% | +$37.6K | ﹤0.01% | 367 |
|
|
2020
Q4 | $103K | Sell |
671
-10
| -1% | -$1.54K | ﹤0.01% | 366 |
|
|
2020
Q3 | $57K | Buy |
681
+208
| +44% | +$17.4K | ﹤0.01% | 424 |
|
|
2020
Q2 | $35K | Buy |
473
+213
| +82% | +$15.8K | ﹤0.01% | 451 |
|
|
2020
Q1 | $11K | Buy |
+260
| New | +$11K | ﹤0.01% | 647 |
|